Dr McLachlan and Dr Dumas both went on maternity leave and we have appointed two new fellows in their place, Dr Cecilia Orbegoso and Dr Clare Pate.
Over the last few months the team have been testing samples for a specific mutation that has the potential to identify which women will benefit from a novel, targeted drug. We are really pleased with the initial results.
Two years on from the launch of the Gynaecological Cancer Fund we are incredibly pleased to report that three review articles have been published in peer-reviewed journals involving the team that you so generously support. It is thanks to your hard work and the funding of research fellows that this research has been carried out and published.